Search

A third (33 per cent) of Brits say they are adjusting their Christmas shopping plans by shopping with charity retailers as a result of the rising cost of living, according to our new survey.

A new health data resource will enable vital research to take place into Covid-19 and cardiovascular disease, with the aim of improving treatments and care for patients.

The BHF House of Care programme found that delivering care and support planning to patients with multiple long-term conditions improves their experience of care and could reduce GP practice costs.

Improved care for people with heart and circulatory disease suffering from Covid-19 could soon be available after we and the National Institute for Health Research (NIHR) announced support for six flagship research programmes.

During the pandemic, we provided the latest coronavirus updates from our experts, including what Covid-19 means for you if you have a heart or circulatory condition.

Doctors say heart scans may prove a useful tool for identifying patients who may benefit from additional treatments to improve their Covid-19 recovery and help prevent potential long-term damage to their heart.

A common antiparasitic drug could block lung damage in people with coronavirus, according to new research part-funded by us and published in Nature.

Magnetic resonance imaging (MRI) scans have found heart damage in around 50 per cent of patients whose blood tests had shown they had some degree of heart injury whilst hospitalised with severe Covid-19 infections.

Researchers funded by us at Edinburgh University have found a new target for treating pulmonary arterial hypertension (PAH). This research could lead to treatments for this deadly condition with no cure.

Our medical experts explain what you need to know about the Covid-19 coronavirus if you have congenital heart disease.